Septic Shock Clinical Trial
— FRIENDOfficial title:
Fluid Responsiveness in Septic Shock Evaluated by Caval Ultrasound Doppler Examination - "FRIEND Study"
NCT number | NCT02676427 |
Other study ID # | 530/15 S-IV |
Secondary ID | |
Status | Recruiting |
Phase | |
First received | |
Last updated | |
Start date | September 2015 |
Est. completion date | June 2021 |
Verified date | August 2019 |
Source | Charles University, Czech Republic |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
The study aims at clarification of venous collapsibility measures with real venous flow measurements during dynamic maneuver testing fluid responsiveness in septic shock patients.
Status | Recruiting |
Enrollment | 60 |
Est. completion date | June 2021 |
Est. primary completion date | May 2021 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - patients in severe sepsis or septic shock - intubation and mechanical ventilation - sedated patient without spontaneous respiratory efforts - central venous catheter in place inserted via right internal jugular vein - signed informed consent by family members Exclusion Criteria: - superior vena cava vascular anomaly - irradiation of neck or mediastinum in medical history - thrombosis of superior vena cava in medical history - atrial fibrillation or other irregular rhythm - permanent or external pacemaker - aggressive mechanical ventilation (PEEP above 10 cm H2O, Pmax above 30 cm H2O) - TOE contraindication (oesophageal varices, stricture, tumour, upper gastrointestinal bleeding) - Pericardial effusion, constrictive pericarditis - Moderate or severe valvular lesion - Severe systolic dysfunction of the left (EF less than 30%) or right ventricle (FAC less than 25%) - Intraabdominal pressure above 20 mmHg - Open chest - Obvious severe hypovolemia ( LVEDA<5.5cm2/m2BSA) |
Country | Name | City | State |
---|---|---|---|
Czechia | Dept of Anaesthesia and Intensive Care, General University Hospital, 1st Medical Faculty, Charles University | Prague 2 |
Lead Sponsor | Collaborator |
---|---|
Charles University, Czech Republic |
Czechia,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Fluid responsiveness | Evaluation of fluid responsiveness, defined as 15% increase of cardiac output after reversible fluid challenge (using PLR - passive leg raise maneuver), by ultrasound doppler evaluation of superior vena caval blood flow respiratory variation. | through the study, data collection during 1 year | |
Secondary | Change of flow | Evaluation of fluid responsiveness by measuring a change of blood flow velocity after PLR maneuver. | through the study, data collection during 1 year | |
Secondary | Respiratory variation of flow velocity | Evaluation of fluid responsiveness by measuring respiratory variation of blood flow velocity in left ventricular outflow tract after PLR maneuver | through the study, data collection during 1 year | |
Secondary | Respiratory collapsibility | Evaluation of fluid responsiveness by measuring respiratory collapsibility of inferior vena cava after PLR maneuver. | through the study, data collection during 1 year | |
Secondary | Respiratory collapsibility | Evaluation of fluid responsiveness by measuring respiratory collapsibility of superior vena cava after PLR maneuver | through the study, data collection during 1 year |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT03649633 -
Vitamin C, Steroids, and Thiamine, and Cerebral Autoregulation and Functional Outcome in Septic Shock
|
Phase 1/Phase 2 | |
Terminated |
NCT04117568 -
The Role of Emergency Neutrophils and Glycans in Postoperative and Septic Patients
|
||
Completed |
NCT04227652 -
Control of Fever in Septic Patients
|
N/A | |
Completed |
NCT05629780 -
Temporal Changes of Lactate in CLASSIC Patients
|
N/A | |
Recruiting |
NCT04796636 -
High-dose Intravenous Vitamin C in Patients With Septic Shock
|
Phase 1 | |
Terminated |
NCT03335124 -
The Effect of Vitamin C, Thiamine and Hydrocortisone on Clinical Course and Outcome in Patients With Severe Sepsis and Septic Shock
|
Phase 4 | |
Recruiting |
NCT04005001 -
Machine Learning Sepsis Alert Notification Using Clinical Data
|
Phase 2 | |
Recruiting |
NCT05217836 -
Iron Metabolism Disorders in Patients With Sepsis or Septic Shock.
|
||
Recruiting |
NCT05066256 -
LV Diastolic Function vs IVC Diameter Variation as Predictor of Fluid Responsiveness in Shock
|
N/A | |
Not yet recruiting |
NCT05443854 -
Impact of Aminoglycosides-based Antibiotics Combination and Protective Isolation on Outcomes in Critically-ill Neutropenic Patients With Sepsis: (Combination-Lock01)
|
Phase 3 | |
Not yet recruiting |
NCT04516395 -
Optimizing Antibiotic Dosing Regimens for the Treatment of Infection Caused by Carbapenem Resistant Enterobacteriaceae
|
N/A | |
Recruiting |
NCT02899143 -
Short-course Antimicrobial Therapy in Sepsis
|
Phase 2 | |
Recruiting |
NCT02565251 -
Volemic Resuscitation in Sepsis and Septic Shock
|
N/A | |
Recruiting |
NCT02580240 -
Administration of Hydrocortisone for the Treatment of Septic Shock
|
N/A | |
Not yet recruiting |
NCT02547467 -
TOADS Study: TO Assess Death From Septic Shock.
|
N/A | |
Terminated |
NCT02335723 -
ASSET - a Double-Blind, Randomized Placebo-Controlled Clinical Investigation With Alteco® LPS Adsorber
|
N/A | |
Completed |
NCT02638545 -
Hemodynamic Effects of Dexmedetomidine in Septic Shock
|
Phase 3 | |
Completed |
NCT02306928 -
PK Analysis of Piperacillin in Septic Shock Patients
|
N/A | |
Completed |
NCT02204852 -
Co-administration of Iloprost and Eptifibatide in Septic Shock Patients
|
Phase 2 | |
Completed |
NCT02079402 -
Conservative vs. Liberal Approach to Fluid Therapy of Septic Shock in Intensive Care
|
Phase 4 |